• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

铂类化疗药物的副作用:化学家的综述。

The side effects of platinum-based chemotherapy drugs: a review for chemists.

机构信息

University of Strathclyde, Glasgow, G4 0NT, UK.

出版信息

Dalton Trans. 2018 May 15;47(19):6645-6653. doi: 10.1039/c8dt00838h.

DOI:10.1039/c8dt00838h
PMID:29632935
Abstract

The platinum-based drugs cisplatin, carboplatin and oxaliplatin are regularly prescribed in the treatment of cancer and while they are effective, their use is limited by their severe, dose-limiting side effects (also referred to as adverse effects/events). In total, a cancer patient can experience any combination of around 40 specific side effects. The dose-limiting side effect for cisplatin is nephrotoxicity, for carboplatin it is myelosuppression, and for oxaliplatin it is neurotoxicity. Other common side effects include anaphylaxis, cytopenias (including leukopenia and neutropenia, thrombocytopenia, and anaemia), hepatotoxicity, ototoxicity, cardiotoxicity, nausea and vomiting, diarrhea, mucositis, stomatitis, pain, alopecia, anorexia, cachexia, and asthenia. The side effects may require patients to be prescribed dose reductions in their platinum drugs of between 25 and 100%. Furthermore, patients require extensive monitoring of their biochemistries, kidney and liver function, and depending on the drug, hearing tests. Finally, patients are commonly co-prescribed additional non-chemotherapy based drugs to treat the side effects which can include antiemetics, antibiotics and myeloid growth factors, mannitol, propafenone, saline hyperhydration, magnesium supplements, monoclonal antibody cytokine blockers, and antioxidants.

摘要

顺铂、卡铂和奥沙利铂等铂类药物常被用于癌症治疗,虽然它们具有疗效,但由于其严重的、剂量限制的副作用(也称为不良反应/事件),其应用受到限制。总的来说,癌症患者可能会经历大约 40 种特定副作用的任意组合。顺铂的剂量限制副作用是肾毒性,卡铂的是骨髓抑制,奥沙利铂的是神经毒性。其他常见的副作用包括过敏反应、血细胞减少症(包括白细胞减少症和中性粒细胞减少症、血小板减少症和贫血)、肝毒性、耳毒性、心脏毒性、恶心和呕吐、腹泻、黏膜炎、口腔炎、疼痛、脱发、食欲不振、恶病质和乏力。副作用可能需要患者减少铂类药物的剂量,减少幅度在 25%到 100%之间。此外,患者需要对其生化、肾功能和肝功能进行广泛监测,并且根据药物的不同,还需要进行听力测试。最后,患者通常还需要同时使用其他非化疗药物来治疗副作用,这些药物包括止吐药、抗生素和骨髓生长因子、甘露醇、普罗帕酮、盐水水化、镁补充剂、单克隆抗体细胞因子阻滞剂和抗氧化剂。

相似文献

1
The side effects of platinum-based chemotherapy drugs: a review for chemists.铂类化疗药物的副作用:化学家的综述。
Dalton Trans. 2018 May 15;47(19):6645-6653. doi: 10.1039/c8dt00838h.
2
Toxicities of the platinum antineoplastic agents.铂类抗肿瘤药物的毒性
Expert Opin Drug Saf. 2003 Nov;2(6):597-607. doi: 10.1517/14740338.2.6.597.
3
Platinum-based drugs: past, present and future.铂类药物:过去、现在与未来。
Cancer Chemother Pharmacol. 2016 Jun;77(6):1103-24. doi: 10.1007/s00280-016-2976-z. Epub 2016 Feb 17.
4
Carboplatin. A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the treatment of cancer.卡铂。对其药效学、药代动力学特性及在癌症治疗中的疗效的初步综述。
Drugs. 1989 Feb;37(2):162-90. doi: 10.2165/00003495-198937020-00005.
5
Structural and functional evaluation of interaction between mammalian ribosomal RNA with platinum-containing antineoplastic drugs.哺乳动物核糖体RNA与含铂抗肿瘤药物相互作用的结构和功能评估
Toxicol Lett. 2016 Feb 3;242:47-52. doi: 10.1016/j.toxlet.2015.11.027. Epub 2015 Nov 30.
6
Phase I studies with carboplatin at the Royal Marsden Hospital.皇家马斯登医院开展的卡铂一期研究。
Cancer Treat Rev. 1985 Sep;12 Suppl A:51-7. doi: 10.1016/0305-7372(85)90018-0.
7
Variation of adverse drug reaction profile of platinum-based chemotherapy with body mass index in patients with solid tumors: an observational study.实体瘤患者中铂类化疗药物不良反应谱随体重指数的变化:一项观察性研究。
Indian J Pharmacol. 2014 Mar-Apr;46(2):222-4. doi: 10.4103/0253-7613.129325.
8
Platinum compounds in children with cancer: toxicity and clinical management.儿童癌症中的铂类化合物:毒性与临床处理。
Anticancer Drugs. 2013 Nov;24(10):1007-19. doi: 10.1097/CAD.0b013e3283650bda.
9
Advances in platinum chemotherapeutics.铂类化疗药物的研究进展。
Chemistry. 2010 Jun 25;16(24):7064-77. doi: 10.1002/chem.201000148.
10
Phase I clinical trial of the novel platin complex dicycloplatin: clinical and pharmacokinetic results.新型铂配合物双环铂的I期临床试验:临床及药代动力学结果
Int J Clin Pharmacol Ther. 2013 Feb;51(2):96-105. doi: 10.5414/CP201761.

引用本文的文献

1
Unresectable Primary Enteric-Type Thymic Adenocarcinoma Treated With FOLFOX Chemotherapy: A Case Report.采用FOLFOX化疗治疗不可切除的原发性肠型胸腺癌:病例报告
Cancer Rep (Hoboken). 2025 Sep;8(9):e70318. doi: 10.1002/cnr2.70318.
2
A Targeted Radiotheranostic Agent for Glioblastoma: [Cu]Cu-NOTA-TP-c(RGDfK).一种用于胶质母细胞瘤的靶向放射诊疗剂:[铜]铜- NOTA - TP - c(RGDfK)
Brain Sci. 2025 Aug 7;15(8):844. doi: 10.3390/brainsci15080844.
3
A bibliometric assessment of research trends and emerging themes at the nexus of chemotherapy and depression.
化疗与抑郁症交叉领域研究趋势和新兴主题的文献计量评估
Naunyn Schmiedebergs Arch Pharmacol. 2025 Aug 12. doi: 10.1007/s00210-025-04500-5.
4
The Role of Platinum-Based Chemotherapy in the Pathogenesis of Tendinosis in Cancer Patients.铂类化疗在癌症患者肌腱病发病机制中的作用。
Cureus. 2025 Jul 12;17(7):e87791. doi: 10.7759/cureus.87791. eCollection 2025 Jul.
5
In-vitro antiproliferative evaluation of newly synthesized titanium(IV) metallacyclic complexes on HeLa and MCF7 cell lines.新合成的钛(IV)金属环配合物对HeLa和MCF7细胞系的体外抗增殖评估
Sci Rep. 2025 Aug 8;15(1):29066. doi: 10.1038/s41598-025-13995-0.
6
Enhanced Anticancer Potential of Pd(II)-Thiosemicarbazone Complexes: Selectivity, Mechanisms, and 3D Models.钯(II)-硫代氨基脲配合物增强的抗癌潜力:选择性、作用机制及三维模型
Pharmaceutics. 2025 Jun 25;17(7):829. doi: 10.3390/pharmaceutics17070829.
7
Novel 3,19-(N-Phenyl-3-(4-fluorophenyl)-pyrazole) Acetal of Andrographolide Promotes Cell Cycle Arrest and Apoptosis in MDA-MB-231 Breast Cancer Cells.新型穿心莲内酯3,19-(N-苯基-3-(4-氟苯基)-吡唑)缩醛促进MDA-MB-231乳腺癌细胞的细胞周期阻滞和凋亡。
Pharmaceuticals (Basel). 2025 Jul 10;18(7):1026. doi: 10.3390/ph18071026.
8
Molecular Design of Catechol-Containing Phospholipid Polymers toward Effective Functionalization of Magnetic Nanoparticles for Cancer Hyperthermia.用于癌症热疗的磁性纳米粒子有效功能化的含儿茶酚磷脂聚合物的分子设计
ACS Omega. 2025 Jul 11;10(28):30708-30716. doi: 10.1021/acsomega.5c02791. eCollection 2025 Jul 22.
9
In Vitro Cytotoxic and Molecular Docking Studies of the Network Pharmacology Approach From Bioactive Compounds of Leaves Against Lung and Breast Cancer Cells.基于树叶生物活性化合物的网络药理学方法对肺癌和乳腺癌细胞的体外细胞毒性及分子对接研究
Adv Pharmacol Pharm Sci. 2025 Jul 11;2025:5946648. doi: 10.1155/adpp/5946648. eCollection 2025.
10
Decreased Expression and Secretion of the Myokine Fndc5/Irisin by Cisplatin Treatment in Mouse Skeletal Muscle.顺铂处理小鼠骨骼肌导致肌动蛋白Fndc5/鸢尾素表达和分泌减少。
Calcif Tissue Int. 2025 Jul 9;116(1):96. doi: 10.1007/s00223-025-01406-5.